Lord, Abbett & Co. LLC Evolus, Inc. Transaction History
Lord, Abbett & Co. LLC
- $31.6 Billion
- Q4 2024
A detailed history of Lord, Abbett & Co. LLC transactions in Evolus, Inc. stock. As of the latest transaction made, Lord, Abbett & Co. LLC holds 497,849 shares of EOLS stock, worth $7.41 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
497,849
Previous 995,449
49.99%
Holding current value
$7.41 Million
Previous $16.1 Million
65.92%
% of portfolio
0.02%
Previous 0.05%
Shares
6 transactions
Others Institutions Holding EOLS
# of Institutions
169Shares Held
48.8MCall Options Held
57.2KPut Options Held
5.5K-
Perceptive Advisors LLC New York, NY5.15MShares$76.6 Million1.9% of portfolio
-
Tang Capital Management LLC San Diego, CA5MShares$74.4 Million4.14% of portfolio
-
Black Rock Inc. New York, NY4.01MShares$59.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.17MShares$47.2 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.13MShares$46.6 Million1.74% of portfolio
About Evolus, Inc.
- Ticker EOLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 56,094,800
- Market Cap $835M
- Description
- Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...